Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | MAPK14 | Q16539 | 4/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.41 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.41 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.41 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | ATR | Q13535 | 2/20 | 0.40 |
| ▸ | PRKACA | P17612 | 1/20 | 0.40 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12840006 | 0.94 | MAPK14 (0.47) | KMT2AMEN1MAPK14TMIGD3RAB9A | |
| SCHEMBL12838993 | 0.93 | TMIGD3 (0.47) | KMT2AMEN1MAPK14TMIGD3RAB9A | |
| SCHEMBL12839000 | 0.93 | KMT2A (0.47) | NPY5RKMT2AMEN1TMIGD3CACNA1G | |
| SCHEMBL12839144 | 0.91 | KMT2A (0.45) | KMT2AMEN1MAPK14TMIGD3RAB9A | |
| SCHEMBL12840399 | 0.91 | KMT2A (0.46) | NPY5RKMT2AMEN1TMIGD3CACNA1G | |
| SCHEMBL12840398 | 0.91 | KMT2A (0.45) | KMT2AMEN1MAPK14TMIGD3RAB9A | |
| SCHEMBL12839149 | 0.90 | KMT2A (0.44) | KMT2AMEN1MAPK14TMIGD3RAB9A | |
| SCHEMBL12840496 | 0.90 | KMT2A (0.46) | NPY5RKMT2AMEN1TMIGD3CACNA1G | |
| SCHEMBL12839145 | 0.90 | MAPK14 (0.45) | KMT2AMEN1MAPK14TMIGD3RAB9A | |
| SCHEMBL12839150 | 0.89 | KMT2A (0.46) | KMT2AMEN1MAPK14TMIGD3RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110070656-A1 | Fluorescent Proteins | JNC CORPORATION (JP) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110070656-A1 | Fluorescent Proteins | CACYBP, CHLSN, LCP2 | NPY5R 3856/4885KMT2A 4653/4885MAPT 3847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.